NUTX

Nutex Health Inc

Price

$206.13

return (12m)

117.37% Logo

p/e

7.92

p/bv

2.81

DIVIDEND YIELD

0.00%
Price

NUTX price

Select period
Select period
Nutex Health Inc
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment NUTX

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
-4.12%
3 months
15.56%
1 year
117.37%
2 years
0.00%
5 years
0.00%
10 years
0.00%
Fundamental indicators

Fundamentals NUTX

Check the fundamentals of Nutex Health Inc shares.

Valuation

P/E
7.92
Sector 7.77
Industry 7.77
P/BV
2.81
Sector 1.72
Industry 1.72
P/Revenue (PSR)
1.68
Sector 1.69
Industry 1.69
EV/EBITDA
9.84
Sector -5,068.50
Industry -5,068.50
EV/EBIT
10.27
Sector -17,869.22
Industry -17,869.22
P/EBITDA
3.71
Sector -12.84
Industry -12.84
P/EBIT
3.92
Sector -10.90
Industry -10.90
P/Total Assets
1.48
Sector 0.81
Industry 0.81
P/Net Current Assets
11.10
Sector -1.83
Industry -1.83
P/Working Capital
3.04
Sector -19.82
Industry -19.82
EPS
26.19
Sector 0.71
Industry 0.71
BVPS
73.84
Sector 9.79
Industry 9.79

Efficiency

Gross Margin
51.26%
Sector 35.82%
Industry 35.82%
EBITDA Margin
60.30%
Sector -189.31%
Industry -189.31%
EBIT Margin
43.02%
Sector 4.44%
Industry 4.44%
Net Profit Margins
21.25%
Sector 2.53%
Industry 2.53%
Asset Turnover
0.22
Sector 0.11
Industry 0.11

Profitability

ROE
35.46%
Sector 2.52%
Industry 2.52%
ROA
18.65%
Sector -0.67%
Industry -0.67%
ROIC
63.58%
Sector -120.09%
Industry -120.09%

Dividends

Dividend yield
0.00%
Sector 0.53%
Industry 0.53%
Payout
0.00%
Sector 9.99%
Industry 9.99%

Debt

Current Ratio
5.00
Sector 1.47
Industry 1.47
Net Debt / EBITDA
-1.37
Sector -19.88
Industry -19.88
Net Debt / EBIT
-1.43
Sector -160,401,241.42
Industry -160,401,241.42
Net Debt / Equity
-0.34
Sector -0.78
Industry -0.78
Gross Debt / Equity
0.06
Sector -0.52
Industry -0.52
Equity/Assets
0.53
Sector 0.43
Industry 0.43
Liabilities/Assets
0.47
Sector 0.52
Industry 0.52

Growth

5Y Revenue CAGR
35.88%
Sector -
Industry -
5Y Earnings CAGR
19.53%
Sector -
Industry -
Fundamental indicators history

Fundamentals NUTX

RETORNO DO INVESTIMENTO

FAIR VALUE OF Nutex Health Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$206.13

Fair Value

$208.60

Upside

1.20%
Because it considers equity value in its calculation, this formula may not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
Buy And Hold Investor Checklist

Nutex Health Inc Buy And Hold Investor Checklist

NUTX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT

Logo Nutex Health Inc

Nutex Health Inc

Average Investor10 user rating

4.0 (0 people)

United States

United States

- year

Founded:

2022

Time since IPO - 4 years

1.037

Employees

Market cap

$1.43 billion

$1.43 billion

Net worth

$507.31 million

$507,312,000.00

Assets

$964.63 million

$964,629,000.00

Total Shares Outstanding

6.87 million

6,870,000

Average Daily Trading Volume

$164.84 Thousand

$164,836.92

Shares

receitas e lucros

NUTX revenue and profits

Financials

Financial Results NUTX

DRAG THE FRAME TO SEE MORE DATA
Financials

NUTX cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - NUTX

Pontos Relevantes

NUTX balance sheet

DRAG THE FRAME TO SEE MORE DATA

Frequently Asked Questions

What is the price of Nutex Health Inc (NUTX) today?

The current price of Nutex Health Inc (NUTX) is $206.13. The stock began the year trading around $164.62 and is currently priced at $206.13. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Nutex Health Inc (NUTX) pay dividends?

Nutex Health Inc (NUTX) did not pay dividends over the past year.

Is Nutex Health Inc (NUTX) a good investment?

Nutex Health Inc (NUTX) is currently trading at $206.13 with a P/E ratio of 7.92. This represents a 528% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 117.37%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nutex Health Inc (NUTX) stock?

You can buy Nutex Health Inc (NUTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NUTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Nutex Health Inc (NUTX) yield today?

Over the past month, Nutex Health Inc (NUTX) has returned -4.12% — 117.37% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Nutex Health Inc (NUTX) today at the current price of $206.13 your total investment would be $20,613.00.

Based on historical performance, the investment would have grown to approximately:

  • $44,806.48 after 1 year
  • $20,613.00 after 5 years
  • $20,613.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.